knowledge -WSS

knowledge

author：knowledge 2025-09-02 11:39:33 - browse：57

Becton Dickinson plans to pay $4.2 billion for Edwards Lifesciences’ critical care business, which sells technology that monitors the heart conditions of critically ill patients.

Edwards had told investors in December 2023 that it planned to spin off the business in order to focus more sharply on addressing structural defects in the heart. BD, meanwhile, wants to increase its monitoring presence in hospitals. In a statement announcing the acquisition, the company touted the “advanced AI algorithms” used in Edwards’ monitors.

BD CEO Tom Polen said in a statement that the acquisition will bolster BD’s portfolio of “AI-enabled clinical decision tools” and digital health products in general.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Medicare Advantage enrollment grows 7.1% to 33.4 million people

knowledge

WSS

Measles policy set amid Florida outbreak alarms vaccine proponents

Ukraine seeks to reclaim its role as a hub for clinical trials

Humans aren't the only ones with an imagination. Rats have it too

Gene therapy’s promise and the high cost of hope

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

Coloradans with cystic fibrosis could lose access to Trikafta

focus

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Wikipedia

Continuity nursing helped my family in our darkest PICU moments

Readout LOUD podcast: ESMO highlights & Roivant's big deal

In age of alternative facts, a scholarly course on calling out crap

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

Continuity nursing helped my family in our darkest PICU moments

Medicare Advantage enrollment hits roughly 33.4 million

At least 13 dead in Texas as scorching temps continue

Surprise medical billing ban raises prices elsewhere

DIEP, the 'gold standard' of breast reconstruction, is under threat

Lung cancer screening guidelines updated for cigarette smokers

Wikipedia

FDA warns medical device makers about rise in fabricated data

After Sarepta trial failure, Duchenne families brace for more debate

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

All of Us, NIH's precision medicine initiative, gets a big boost

Congress may force more Covid

Flagship Pioneering startup Sonata Therapeutics lays off 21

hotspot

hotspot

knowledge

hotspot